Security key
36315X101
Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG)
CUSIP: 36315X101
Q3 2015 13F Holders as of 30 Sep 2015
- Type / Class
- Equity / Ordinary shares, no par value
- Shares outstanding
- 66,186,595
- Total 13F shares
- 9,048,062
- Share change
- +264,382
- Total reported value
- $368,347,081
- Price per share
- $40.71
- Number of holders
- 37
- Value change
- +$6,558,839
- Number of buys
- 26
- Number of sells
- 22
Report period
Q3 2015
Institutions
37
Top holders
10
GLPG full security history
Newer quarter: Q4 2015
Previous quarter: Q2 2015
Lakefront Biotherapeutics NV SEC filings
Lakefront Biotherapeutics NV company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36315X101
Recent filing periods:
Top shareholders of GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
5.9%
|
3,889,458
|
$200,307,000 | — | 30 Jun 2015 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.7%
|
1,100,000
|
$56,650,000 | — | 30 Jun 2015 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.2%
|
765,952
|
$39,447,000 | — | 30 Jun 2015 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.97%
|
642,608
|
$33,094,000 | — | 30 Jun 2015 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.77%
|
512,900
|
$26,414,000 | — | 30 Jun 2015 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.56%
|
369,276
|
$19,018,000 | — | 30 Jun 2015 | |
| RS INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.43%
|
282,340
|
$14,541,000 | — | 30 Jun 2015 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.34%
|
225,000
|
$11,588,000 | — | 30 Jun 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
169,582
|
$8,733,000 | — | 30 Jun 2015 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.23%
|
152,500
|
$7,854,000 | — | 30 Jun 2015 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.23%
|
150,000
|
$7,725,000 | — | 30 Jun 2015 | |
| Zweig-DiMenna Associates LLC |
13F
|
Company |
0.21%
|
140,000
|
$7,210,000 | — | 30 Jun 2015 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.08%
|
53,000
|
$2,730,000 | — | 30 Jun 2015 | |
| Atika Capital Management LLC |
13F
|
Company |
0.06%
|
40,100
|
$2,065,000 | — | 30 Jun 2015 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.06%
|
39,320
|
$2,025,000 | — | 30 Jun 2015 | |
| BlackRock Group LTD |
13F
|
Company |
0.05%
|
33,300
|
$1,715,000 | — | 30 Jun 2015 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
32,695
|
$1,684,000 | — | 30 Jun 2015 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.03%
|
20,000
|
$1,030,000 | — | 30 Jun 2015 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.03%
|
20,000
|
$1,030,000 | — | 30 Jun 2015 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.03%
|
20,000
|
$1,030,000 | — | 30 Jun 2015 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.02%
|
15,400
|
$793,000 | — | 30 Jun 2015 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.02%
|
15,300
|
$788,000 | — | 30 Jun 2015 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.02%
|
13,127
|
$676,000 | — | 30 Jun 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
12,498
|
$644,000 | — | 30 Jun 2015 | |
| NAVELLIER & ASSOCIATES INC |
13F
|
Company |
0.02%
|
12,035
|
$620,000 | — | 30 Jun 2015 | |
| GLG Partners LP |
13F
|
Company |
0.02%
|
11,219
|
$578,000 | — | 30 Jun 2015 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
10,511
|
$541,000 | — | 30 Jun 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
10,000
|
$515,000 | — | 30 Jun 2015 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
9,600
|
$494,000 | — | 30 Jun 2015 | |
| E. E. Geduld |
13F
|
Individual |
0.01%
|
5,000
|
$258,000 | — | 30 Jun 2015 | |
| FolioMetrix LLC |
13F
|
Company |
0.01%
|
3,400
|
$189,000 | — | 30 Jun 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.01%
|
3,400
|
$175,000 | — | 30 Jun 2015 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,500
|
$129,000 | — | 30 Jun 2015 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2,300
|
$117,000 | — | 30 Jun 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
950
|
$49,000 | — | 30 Jun 2015 | |
| Invesco Ltd. |
13F
|
Company |
0%
|
839
|
$43,000 | — | 30 Jun 2015 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
420
|
$22,000 | — | 30 Jun 2015 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
300
|
$15,000 | — | 30 Jun 2015 | |
| Edge Wealth Management LLC |
13F
|
Company |
0%
|
200
|
$10,000 | — | 30 Jun 2015 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
50
|
$3,000 | — | 30 Jun 2015 |
Institutional Holders of Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) as of Q3 2015
As of 30 Sep 2015,
Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,048,062 shares.
The largest 10 holders included
FMR LLC, FEDERATED INVESTORS INC /PA/, GILDER GAGNON HOWE & CO LLC, ADAGE CAPITAL PARTNERS GP LLC, ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, GOLDMAN SACHS GROUP INC, and Rock Springs Capital Management LP.
This page lists
37
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2015 vs Q2 2015 Across Filers
Q2 2015 holders
40
Q3 2015 holders
37
Holder diff
-3
| Investor | Q2 2015 Shares | Q3 2015 Shares | Share Diff | Share Chg % | Q2 2015 Value $ | Q3 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.